Ebselen, a new candidate therapeutic against SARS-CoV-2

Int J Surg. 2020 Dec;84:53-56. doi: 10.1016/j.ijsu.2020.10.018. Epub 2020 Oct 23.

Authors

C V Haritha¹, Khan Sharun², Bosco Jose³

Affiliations

¹ Division of Pharmacology and Toxicology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India.
² Division of Surgery, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India. Electronic address: sharunkhansk@gmail.com.
³ Division of Physiology & Climatology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, 243 122, Uttar Pradesh, India.

No abstract available

Keywords: COVID-19; Clinical trials; Ebselen; Main protease; Repurposed drug; SARS-CoV-2; Therapeutics.

Publication types

Letter
Comment

MeSH terms

Azoles
COVID-19*
Humans
Isoindoles
Laboratories
Organoselenium Compounds
Polymerase Chain Reaction
SARS-CoV-2*
Tomography, X-Ray Computed

Substances

Azoles
Isoindoles
Organoselenium Compounds
ebselen